第7章 市場機會及未來趨勢

目錄

Product Code: 67789

Market Overview

The global comprehensive metabolic panel market is primarily driven by the growing awareness among the population regarding early diagnosis and treatment of diseases. In addition, advancements in point of care technologies and diagnostics are expected to boost market growth over the coming years.

Furthermore, the increase in the prevalence of chronic diseases and the rise in geriatric population are contributing to the growth of the market. According to the International Diabetes Federation (IDF), in 2019, about 463 million adults were living with diabetes and expected to reach 700 million by 2045. The burden of diabetes and efforts of government and other organizations in increasing awareness among the population is anticipated to boost the market growth over the forecast period. Moreover, the lack of skilled professionals and stringent regulatory policies expected to hamper the market growth over the forecast period.

Scope of the Report

The comprehensive metabolic panel is the group of blood tests that provides the information regarding the different body fluids thus helps the diagnosis of the various diseases.

Key Market Trends

Diabetes Disease Segment is Projected to Grow at Healthy Growth Rate

The increase in demand for immediate diagnosis and advent of new technologies transforming the point of care testing devices thus projected bolster the market growth over the forecast period.

Moreover, the introduction and implementation of data-driven solutions in diagnostic for better evaluation of health conditions driving the market growth furthermore.

Kidney disease segment having a notable share in the diseases segment. The share is anticipated to the growing prevalence of kidney disease and increasing emphasis on early diagnosis among the people.

Besides, growing consumption of alcohol leading to liver diseases thus rise in emphasis on early diagnosis and testing expected to positively impact the growth of the market.

Owing to factors such as a sedentary lifestyle, changing food habits and increasing diabetic patients around the world, diabetes disease segments expected to grow at a significant growth rate over the period.

North America is Anticipated to Grow at Significant Growth Rate

North America is anticipated to have a significant share and projected to continue over the period. The growth is attributed to well-established healthcare infrastructure, the presence of major players and the presence of a large pool of the patient population. Furthermore, favorable reimbursement policies and government support in the region is anticipated to aid the market growth in the region. The Asia Pacific region is expected to have considerable market growth over the forecast period owing to the rise in healthcare spending and awareness among the population. Also, there is a significant market gap between supply and demand in emerging countries such as India and China, coupled with companies' interest in expanding into these geographies will drive the market growth.

Competitive Landscape

The comprehensive metabolic panel market is moderately competitive having local and international players in the market. Companies are focusing on collaborations and expanding into new geographies to strengthen their market share. The key players operating in this market include Quest Diagnostics, Laboratory Corporation of America Holdings, ARUP Laboratories, Synlab Hrvatska . and UNIPATH among others.